• Science and Research

  Kalydeco Approved to Treat 6- to 12-month-old Infants with Cystic Fibrosis

  Posted by cystic-fibrosis-news-moderator on May 6, 2019 at 6:33 pm

  Kalydeco has been approved in the U.S. to treat infants from six to 12 months old, who have cystic fibrosis and at least one CFTR gene mutation. Click here to read more about this news.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 5 years ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply